CXCL12 and rheumatoid arthritis: Monocytes from patients with active RA, or in clinical remission, did not differ in their capability to respond to CXCL12 (Figure 1A), and as demonstrated in monocytes from HD (21), they did not migrate in response to HMGB1 alone (data not shown).